期刊文献+

l-苏糖酸亚铁治疗缺铁性贫血的疗效

Effect of ferrous l-threonate in treatment of iron deficiency anemia
下载PDF
导出
摘要 目的 :观察l 苏糖酸亚铁治疗缺铁性贫血的疗效及安全性。方法 :采用随机、双盲、双模拟、阳性药物平行对照临床试验方法。 4 8例合格受试者分别给予事先编盲的药物 ,分 2组 ,试验组 (2 4例 )给予l 苏糖酸亚铁胶囊 4粒 +模拟琥珀酸亚铁片 2片 ,po ,tid ,对照组 (2 4例 )给予琥珀酸亚铁片 2片 +模拟l 苏糖酸亚铁胶囊 4粒 ,po ,tid。试验周期为 8wk。结果 :治疗后 4wk对照组总有效率 86 % ,试验组总有效率 10 0 %。治疗后 8wk ,对照组、试验组总有效率均为 10 0 %。 2组疗效比较无显著差别(P >0 .0 5 )。不良反应的发生率对照组为 4例(19% ) ,试验组为 2例 (9% ) ,差别无显著意义(P >0 .0 5 )。结论 :l 苏糖酸亚铁用于治疗缺铁性贫血起效快、疗效显著 ,不良反应轻微 ,发生率低。 AIM: To evaluate the effect and safety of ferrous l-threonate in treating iron deficiency anemia. METHODS: A random, double blind, double modeling and parallel comparative study with positive control was desiged. Forty-eight eligible patients were randomly divided into trial group(n=24) and positive control group(n=24). Patients in trial group were given ferrous l-threonate plus the modeling ferrous succinate, and patients in control group were given ferrous succinate plus the modeling ferrous l-threonate. The treatment course was 8 wk. The clinical effective evaluation was made at 4,8 wk. RESULTS: After 4 wk treatment,the total effective rate was 86 % in the control group and 100 % in the trial group.After 8 wk treatment , the total effective rate was 100 % in both control group and trial group.There was no significant difference between two groups(P> 0.05). Adverse reactions occurred in only 4(19 %) patients in control group,and only 2(9 %)patients in trial group. There were no significant differences between two groups(P>0.05). CONCLUSION: The effect of ferrous l-threonate in treating iron deficiency anemia is certain,significant and rapid. Its adverse reactions are few and minimal.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2004年第5期296-299,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 贫血 缺铁性 临床试验 Ⅲ期 随机对照试验 双盲法 l-苏糖酸亚铁 琥珀酸亚铁 anemia, iron deficiency clinical trials,phase Ⅲ randomized controlled trial double-blind method ferrous l-threonate ferrous succinate
  • 相关文献

参考文献5

  • 1YU K, BAO CY, WANG CX, et al.Experimental report on ferrous l-threonate improvement on nutritional anemia[J]. Chin Child Blood (in Chinese) ,1998,3(3):109-111.
  • 2YU K, WANG ZW, KOU FP, et al.Experimental observation on ferrous l-threonate improvement on nutritional iron deficiency anemia[J]. Chin Child Blood (in Chinese),1998,3(1):7-8.
  • 3CHEN LS, CAO RN, TANG J, et al.Evaluation on clinic effect of ferrous succinate treatment with iron deficiency anemia[J]. Acta Acad Med Xuzhou(in Chinese),2001,21(2):112-113.
  • 4王蕾,王刚,李廷谦,张瑞明.国外药品临床试验中的伦理学现状及思考[J].中国新药与临床杂志,2003,22(10):628-632. 被引量:13
  • 5林果为,陈波斌.铁缺乏症的临床流行病学研究[J].上海医学,1999,22(2):74-77. 被引量:22

二级参考文献22

  • 1林果为,郑仙梅,丁训杰.上海市静安区青少年铁营养状况的调查[J].上海医学,1989,12(5):280-283. 被引量:7
  • 2林果为 黄一微 等.四种常用铁参数对缺乏症诊断价值的评价[J].中华血液学杂志,1990,11:282-282.
  • 3林果为 丁训杰 等.上海地区缺铁性贫血的研究[J].中华血液学杂志,1990,11:473-473.
  • 4林果为 郑仙梅 等.上海西区纺织女工中铁缺乏症的调查[J].中华血液学杂志,1985,6:705-705.
  • 5BAYER A, TADD W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study[J]. BMJ, 2000, 321(7267): 992-993.
  • 6ANN. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects [J ]. JAMA, 2000, 284(23):3043-3045.
  • 7BAER N. Debate about placebos points to issue surrounded by many shades of grey[J]. CMAJ, 1996, 155(10) : 1475-1476.
  • 8ROTHMAN KJ, MICHELS KB. The continuing unethical use of placebo controls[J]. N Engl J Med, 1994, 331(6) :394-398.
  • 9KERRIDGE I, LOWE M, HENRY D. Ethics and evidence based medicine[J]. BMJ, 1998 , 316(7138) :1151-1153.
  • 10GUYATT GH, SACKETT DL, COOK DJ. Usere' guides to the medical literature. Ⅱ. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? [J]. JAMA, 1994, 271(1): 59-63.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部